Active Ingredient(s): Ceftolozane + Tazobactam
FDA Approved: * December 19, 2014
Pharm Company: * CUBIST PHARMS INC
Category: Antibiotics

Ceftolozane/tazobactam, sold under the brand name Zerbaxa, is a combination antibiotic medication used for the treatment of complicated urinary tract infections and complicated intra-abdominal infections in adults.[3][2][4] Ceftolozane is a cephalosporin antibiotic, developed for the treatment of infections with gram-negative bacteria that are resistant to conventional antibiotics.[5] It was studied for urinary tract infections, ... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Zerbaxa Intravenous Injection, Powder, Lyophilized, for Solution
NDC: 67919-030
Cubist Pharmaceuticals, Inc.